Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response.
about
P1343
DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic miSpecies specificity and augmentation of responses to class II major histocompatibility complex molecules in human CD4 transgenic mice.Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positionsIdentification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV.Targeting p53 as a general tumor antigen.HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses.Human CD8 T cells generated in vitro from hematopoietic stem cells are functionally mature.Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis.The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetesSpecific tolerance across a discordant xenogeneic transplantation barrier.Beyond HLA-A*0201: new HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8+ T cell epitopes.HLA class I transgenic mice: development, utilisation and improvement.Xenogeneic proliferation and lymphokine production are dependent on CD4+ helper T cells and self antigen-presenting cells in the mouse.Conformational differences in major histocompatibility complex-peptide complexes can result in alloreactivity.Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1Human CD8 transgene regulation of HLA recognition by murine T cells.Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes.Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses.The hemochromatosis protein HFE 20 years later: An emerging role in antigen presentation and in the immune systemMolecular interactions in the activation of effector and precursor cytotoxic T lymphocytes.Immunological characteristics of islet cell xenotransplantation in humans and rodents.Xenograft tolerance.Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant regionGeneration of β cell-specific human cytotoxic T cells by lentiviral transduction and their survival in immunodeficient human leucocyte antigen-transgenic mice.Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex.Testing mouse mammary tumor virus superantigen as adjuvant in cytotoxic T-lymphocyte responses against a melanoma tumor antigen.Generating p53-specific cytotoxic T lymphocytes by recombinant adenoviral vector-based vaccination in mice, but not man.Evaluation of immune-mediated idiosyncratic drug toxicity using chimeric HLA transgenic mice.A transgenic mouse model for HLA-B*57:01-linked abacavir drug tolerance and reactivity.Xenotransplantation
P2860
Q27473069-F7253063-6158-4320-88F2-53B99D34D020Q30434357-9BD94382-6A68-4AEA-86D7-5CD9CB15C07AQ30448796-639C07BD-7884-449C-A9C7-0E3EA07B16F3Q30951751-458C992E-6215-468D-9E89-B39A505344C3Q33638172-72D8699A-CBD6-48DE-A0FF-F50E8B5E6B41Q33755226-5E02B96C-1C7D-4037-A164-4DA82A8252F6Q33853349-BA8D776A-C849-45D7-86DC-A9ACDE3818CFQ34642305-ABB185FD-FA6F-45E4-B457-8AA8D076957CQ35787117-86A29120-5C82-4B26-9E5E-BF9DDA5AAD25Q35882473-D528FEEC-0ABB-44F3-9EC2-2BA3164D2D06Q35981325-3456978E-CAF3-4913-8C54-F1AD70D8A014Q36194073-7106EEB6-F7C1-42EC-8509-42AA76A3242FQ36352670-D224E1B9-58C9-4DD0-8FF5-0C3676B283CAQ36362680-D48AAAF4-D1B9-4B1D-974C-1AF1D94D9995Q36363763-3022997C-F9E6-4802-949D-2C002FA73125Q36365522-54F6D88F-E13A-471E-A9B7-546970239F90Q36376876-868E0454-2EDB-4D6A-AEA9-4A69EF3ACD2DQ37385100-354EFB7C-78A4-48FD-A439-87C5359F67CAQ39285519-589CB882-96D2-4213-AE64-98B20789E9C9Q40378882-AAF8FABB-7602-4E11-82CF-6DE2CF7A11A3Q40600281-174F36C7-A64A-4858-9D09-2376290C0500Q40600287-42869BF3-BCB8-48A0-A4BE-C9761BA930A5Q41306886-81E036F0-A0F7-4F1A-AB00-91DB494339BDQ42183951-B2F01365-20D0-4E17-BA10-0A80F89599DFQ42941471-E1B00E8A-9F49-44C4-9C63-85156660136BQ45732747-279BF78E-4373-4D11-BA22-01417ABB1EB6Q45887190-E0E46F45-F9EE-49CC-9E27-0B63DFA52350Q49909599-85FC6FC6-CDC0-44EA-AA03-95333938C508Q54204422-C7386CF4-BB82-4FCB-A24B-299396E50A38Q56777177-2EC152BC-B2C0-492F-A87A-DEA1AC379413
P2860
Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Species-restricted interaction ...... de of the xenogeneic response.
@en
Species-restricted interaction ...... de of the xenogeneic response.
@nl
type
label
Species-restricted interaction ...... de of the xenogeneic response.
@en
Species-restricted interaction ...... de of the xenogeneic response.
@nl
prefLabel
Species-restricted interaction ...... de of the xenogeneic response.
@en
Species-restricted interaction ...... de of the xenogeneic response.
@nl
P2860
P356
P1476
Species-restricted interaction ...... de of the xenogeneic response.
@en
P2093
P2860
P304
P356
10.1084/JEM.170.4.1091
P407
P4510
P577
1989-10-01T00:00:00Z